Colgate-Palmolive Company

CL · Consumer Defensive

$88.28
+0.19% today

What a holder would want to know before buying CL: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $74.98 · Nov 2025High $99.14 · Feb 2026

Today’s price is 18% above the lowest point of the past year and 11% below the highest.

Over the past year it was cheaper than today on 58% of days and more expensive on 42%. Over the last 10 years: cheaper on 85% of days.

Right at its average price of the last 200 trading days.

How bad does it get

Fell 20% or more twice in 10 years. The deepest fall was 25%; the longest took 3.2 years to get back to its peak. Every one recovered.

Now 19% below the Sep 2024 peak.

Dec 2020
−21%back in 3.2 years
Jan 2018
−25%back in 2.6 years
What you own

Colgate-Palmolive Company · Consumer Defensive · Household & Personal Products · a large company worth $70.37B

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $20.38B in 2025, with $2.13B of profit. Sales grew in 3 of the last 3 years.

Keeps about 10 cents of every dollar of sales as profit.

Is it healthy?
Cash
$1.45B
Debt
$7.86B
Free cash flow / yr
$3.46B

Would need about 2.3 years of free cash flow to repay all its debt.

Is it expensive?

You pay $35 for every $1 of last year’s profit, and $22 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 2.41% a year in dividends at today’s price · next ex-dividend Oct 20.

What others are doing

21 analysts: 13 say buy, 8 hold, 0 sell. Their average 12-month target is $98.25 (range $87.00–$110.00).

Insiders made 0 purchases and 5 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy CL with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.